Literature DB >> 16407780

Murine models of susceptibility to tuberculosis.

Gillian L Beamer1, Joanne Turner.   

Abstract

Approximately one third of the world's population is infected with Mycobacterium tuberculosis,yet each year a small proportion of those individuals progress to an active disease state. Early identification and treatment of such individuals is essential to reduce transmission; however, genetic and immunological correlates of disease progression have not been well established in man. The murine model has been a central tool for the elucidation of protective immune mechanisms that are essential for controlling M. tuberculosis infection. Additionally, the study of inbred mice has revealed significant divergence in the susceptibility and disease progression of individual mouse strains to an infection with M.tuberculosis. The continued study of genetically disparate mouse strains has the potential to identify immune mechanisms that correlate with increasing susceptibility to tuberculosis. These mechanisms will be highly applicable to studies in man and assist in the early detection of individuals that are more vulnerable to the development of reactivation tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16407780

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  17 in total

Review 1.  The non-human primate model of tuberculosis.

Authors:  D Kaushal; S Mehra; P J Didier; A A Lackner
Journal:  J Med Primatol       Date:  2012-03-20       Impact factor: 0.667

Review 2.  Tuberculosis in the elderly: Why inflammation matters.

Authors:  Tucker J Piergallini; Joanne Turner
Journal:  Exp Gerontol       Date:  2017-12-26       Impact factor: 4.032

3.  H-2 alleles contribute to antigen 85-specific interferon-gamma responses during Mycobacterium tuberculosis infection.

Authors:  Gillian L Beamer; Joshua Cyktor; Bridget Carruthers; Joanne Turner
Journal:  Cell Immunol       Date:  2011-06-12       Impact factor: 4.868

4.  Ultra-low dose of Mycobacterium tuberculosis aerosol creates partial infection in mice.

Authors:  Divey Saini; Gregory W Hopkins; Sarah A Seay; Ching-Ju Chen; Casey C Perley; Eva M Click; Richard Frothingham
Journal:  Tuberculosis (Edinb)       Date:  2011-12-21       Impact factor: 3.131

5.  IL-10 inhibits mature fibrotic granuloma formation during Mycobacterium tuberculosis infection.

Authors:  Joshua C Cyktor; Bridget Carruthers; Rachel A Kominsky; Gillian L Beamer; Paul Stromberg; Joanne Turner
Journal:  J Immunol       Date:  2013-02-08       Impact factor: 5.422

6.  Lung necrosis and neutrophils reflect common pathways of susceptibility to Mycobacterium tuberculosis in genetically diverse, immune-competent mice.

Authors:  Muhammad K K Niazi; Nimit Dhulekar; Diane Schmidt; Samuel Major; Rachel Cooper; Claudia Abeijon; Daniel M Gatti; Igor Kramnik; Bulent Yener; Metin Gurcan; Gillian Beamer
Journal:  Dis Model Mech       Date:  2015-07-23       Impact factor: 5.758

Review 7.  Animals devoid of pulmonary system as infection models in the study of lung bacterial pathogens.

Authors:  Yamilé López Hernández; Daniel Yero; Juan M Pinos-Rodríguez; Isidre Gibert
Journal:  Front Microbiol       Date:  2015-02-04       Impact factor: 5.640

8.  Genetically diverse mice are novel and valuable models of age-associated susceptibility to Mycobacterium tuberculosis.

Authors:  David E Harrison; Gillian L Beamer; Clinton M Astle; M Khalid Khan Niazi; Samuel Major
Journal:  Immun Ageing       Date:  2014-12-16       Impact factor: 6.400

9.  Clonal expansions of CD8+ T cells with IL-10 secreting capacity occur during chronic Mycobacterium tuberculosis infection.

Authors:  Joshua C Cyktor; Bridget Carruthers; Gillian L Beamer; Joanne Turner
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

10.  Use of a Contained Mycobacterium tuberculosis Mouse Infection Model to Predict Active Disease and Containment in Humans.

Authors:  Fergal J Duffy; Gregory S Olson; Elizabeth S Gold; Ana Jahn; Alan Aderem; John D Aitchison; Alissa C Rothchild; Alan H Diercks; Johannes Nemeth
Journal:  J Infect Dis       Date:  2022-05-16       Impact factor: 7.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.